📊 Note: Daily ratings and analytics are updated after market close and will be available by 7:00 PM IST.

Details

NameSymbolSector
JAGSONPAL PHARMACEUTICALS LIMITEDJAGSNPHARMPharmaceuticals
Open
225.6
High
232
Low
222.71
Close
224.31
Volume
60823
Exchange
nse
Time
15-Jul-2026

Outlook

Score:  

3

Rating:  

RISKY

Candlestick Pattern

Candle pattern of Jagsonpal Pharmaceuticals is  
High Wave
Estimated Stoploss of Jagsonpal Pharmaceuticals is ₹  
232
Jagsonpal Pharmaceuticals has a  
Bearishℹ
 pattern. 
Formation of  
High Wave
 candle pattern indicates the trend direction of Jagsonpal Pharmaceuticals is  
Unpredictableℹ
. 

Trend

Jagsonpal Pharmaceuticals is in  
Sideways trendℹ
. 
Price of Jagsonpal Pharmaceuticals is  
Upℹ
 by  

3.13

%. 
Target
Buy @ 

184.62

Sell @ 

238.4

Current @ 

224.31

Volume

The trade volumes of Jagsonpal Pharmaceuticals have become  
Deficientℹ
Though the volume trend for Jagsonpal Pharmaceuticals appears  
Bullishℹ
 the participants seem to be  
Weak Buyersℹ
The trade volume of Jagsonpal Pharmaceuticals is  

Down

 by  

81.66

% 

Valuation

The current market price of Jagsonpal Pharmaceuticals is  
Undervaluedℹ

Financials

Balance
With total liablities and shareholder equity worth ₹ 278cr and total assets worth ₹ 278cr, the balance sheet of Jagsonpal Pharmaceuticals is:  
Balancedℹ
. 
Cashflow
Jagsonpal Pharmaceuticals has  
Poorℹ
 cash flow because there is  

Shortage

 of  

₹ 1cr

. It is  
Downℹ
 by  

200

%. 

(*Mar 2025)

49.55% i.e. ₹ 55cr earned in operatingℹ
40.54% i.e. ₹ 45cr spent in investingℹ
9.91% i.e. ₹ 11cr spent in financingℹ
0% in otherℹ
Jagsonpal Pharmaceuticals has  
Maintainedℹ
 cash flow because there is  

Surplus

 of  

₹ 1cr

. It is  
Upℹ
 by  

109.09

%. 

(*Mar 2024)

52.24% i.e. ₹ 35cr earned in operatingℹ
35.82% i.e. ₹ 24cr spent in investingℹ
11.94% i.e. ₹ 8cr spent in financingℹ
0% in otherℹ
Income
The income of Jagsonpal Pharmaceuticals is  

₹ 77cr

 and  

Profit

 is :  

₹ 12cr

(*Sep 2025)

Jagsonpal Pharmaceuticals Profit is up by:  

20

% and Income is Down by:  

1.28

% 

(*Sep 2025)

The income of Jagsonpal Pharmaceuticals is  

₹ 78cr

 and  

Profit

 is :  

₹ 10cr

(*Jun 2025)

Jagsonpal Pharmaceuticals Profit is up by:  

66.67

% and Income is Up by:  

27.87

% 

(*Jun 2025)

The income of Jagsonpal Pharmaceuticals is  

₹ 61cr

 and  

Profit

 is :  

₹ 6cr

(*Mar 2025)

Jagsonpal Pharmaceuticals Profit is down by:  

80.65

% and Income is Down by:  

19.74

% 

(*Mar 2025)

Market Cap

Market capital of Jagsonpal Pharmaceuticals Limited is 1350cr

Top Rated Competitors

NameScore
RPG Life Sciences Limited
6
BDH Industries Ltd.
6
KIMIA BIOSCIENCES LIMITED
5.75
Marksans Pharma Ltd.
5.75
Pfizer Ltd.
5.5
Abbott India Ltd.
5.5
Kilitch Drugs (I) Ltd.
5.5
Lactose (India) Ltd.
5.25
Fredun Pharmaceuticals Limited
5.25
Lupin Ltd
5.25
By using this site you agree to the use of cookies to deliver a better site experience.